Phase II multi-step planning methods in oncology: Comparison, recommendations and potential applications
- 31 May 2007
- journal article
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 28 (3) , 249-257
- https://doi.org/10.1016/j.cct.2006.08.012
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Administration Propeukin Program Cooperative GroupJournal of Clinical Oncology, 2003
- Statistical design in phase II clinical trials and its application in breast cancerThe Lancet Oncology, 2003
- Stopping rules for phase II studiesBritish Journal of Clinical Pharmacology, 2001
- New statistical strategy for monitoring safety and efficacy in single-arm clinical trials.Journal of Clinical Oncology, 1996
- An optimal three‐stage design for phase II clinical trialsStatistics in Medicine, 1994
- Application of the triangular test to phase II cancer clinical trialsStatistics in Medicine, 1990
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- The analysis of sequential clinical trialsBiometrika, 1979
- Estimation following sequential testsBiometrika, 1978
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961